Literature DB >> 10944526

CREB-binding protein/p300 activates MyoD by acetylation.

A Polesskaya1, A Duquet, I Naguibneva, C Weise, A Vervisch, E Bengal, F Hucho, P Robin, A Harel-Bellan.   

Abstract

The myogenic protein MyoD requires two nuclear histone acetyltransferases, CREB-binding protein (CBP)/p300 and PCAF, to transactivate muscle promoters. MyoD is acetylated by PCAF in vitro, which seems to increase its affinity for DNA. We here show that MyoD is constitutively acetylated in muscle cells. In vitro, MyoD is acetylated both by CBP/p300 and by PCAF on two lysines located at the boundary of the DNA binding domain. MyoD acetylation by CBP/p300 (as well as by PCAF) increases its activity on a muscle-specific promoter, as assessed by microinjection experiments. MyoD mutants that cannot be acetylated in vitro are not activated in the functional assay. Our results provide direct evidence that MyoD acetylation functionally activates the protein and show that both PCAF and CBP/p300 are candidate enzymes for MyoD acetylation in vivo.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10944526     DOI: 10.1074/jbc.M003815200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  49 in total

1.  Interaction between acetylated MyoD and the bromodomain of CBP and/or p300.

Authors:  A Polesskaya; I Naguibneva; A Duquet; E Bengal; P Robin; A Harel-Bellan
Journal:  Mol Cell Biol       Date:  2001-08       Impact factor: 4.272

2.  A Suv39h-dependent mechanism for silencing S-phase genes in differentiating but not in cycling cells.

Authors:  Slimane Ait-Si-Ali; Valentina Guasconi; Lauriane Fritsch; Hakima Yahi; Redha Sekhri; Irina Naguibneva; Philippe Robin; Florence Cabon; Anna Polesskaya; Annick Harel-Bellan
Journal:  EMBO J       Date:  2004-02-05       Impact factor: 11.598

3.  Coactivator-dependent acetylation stabilizes members of the SREBP family of transcription factors.

Authors:  Valeria Giandomenico; Maria Simonsson; Eva Grönroos; Johan Ericsson
Journal:  Mol Cell Biol       Date:  2003-04       Impact factor: 4.272

4.  In vitro transcription system delineates the distinct roles of the coactivators pCAF and p300 during MyoD/E47-dependent transactivation.

Authors:  F Jeffrey Dilworth; Karen J Seaver; Anna L Fishburn; Steve L Htet; Stephen J Tapscott
Journal:  Proc Natl Acad Sci U S A       Date:  2004-08-02       Impact factor: 11.205

5.  MyoD directly up-regulates premyogenic mesoderm factors during induction of skeletal myogenesis in stem cells.

Authors:  Peter J Gianakopoulos; Virja Mehta; Anastassia Voronova; Yi Cao; Zizhen Yao; Josée Coutu; Xiaonan Wang; Michelle S Waddington; Stephen J Tapscott; Ilona S Skerjanc
Journal:  J Biol Chem       Date:  2010-11-15       Impact factor: 5.157

6.  p300 is not required for metabolic adaptation to endurance exercise training.

Authors:  Samuel A LaBarge; Christopher W Migdal; Elisa H Buckner; Hiroshi Okuno; Ilya Gertsman; Ben Stocks; Bruce A Barshop; Sarah R Nalbandian; Andrew Philp; Carrie E McCurdy; Simon Schenk
Journal:  FASEB J       Date:  2015-12-28       Impact factor: 5.191

7.  Acetylation is important for MyoD function in adult mice.

Authors:  Arnaud Duquet; Anna Polesskaya; Sylvain Cuvellier; Slimane Ait-Si-Ali; Patrick Héry; Linda L Pritchard; Matthieu Gerard; Annick Harel-Bellan
Journal:  EMBO Rep       Date:  2006-10-06       Impact factor: 8.807

8.  The c-MYC oncoprotein is a substrate of the acetyltransferases hGCN5/PCAF and TIP60.

Authors:  Jagruti H Patel; Yanping Du; Penny G Ard; Charles Phillips; Beth Carella; Chi-Ju Chen; Carrie Rakowski; Chandrima Chatterjee; Paul M Lieberman; William S Lane; Gerd A Blobel; Steven B McMahon
Journal:  Mol Cell Biol       Date:  2004-12       Impact factor: 4.272

9.  Down regulation of the interleukin-8 promoter by human papillomavirus type 16 E6 and E7 through effects on CREB binding protein/p300 and P/CAF.

Authors:  Shih-Min Huang; D J McCance
Journal:  J Virol       Date:  2002-09       Impact factor: 5.103

10.  Differential role of p300 and CBP acetyltransferase during myogenesis: p300 acts upstream of MyoD and Myf5.

Authors:  Jeanne-Françoise Roth; Noriko Shikama; Clea Henzen; Isabelle Desbaillets; Werner Lutz; Silvia Marino; Jonas Wittwer; Hubert Schorle; Max Gassmann; Richard Eckner
Journal:  EMBO J       Date:  2003-10-01       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.